Bio-Rad Laboratories, Inc. (NYSE:BIO) agreed to acquire Curiosity Diagnostics Sp. z o.o. from Scope Fluidics S.A. (WSE:SCP) for $100 million on August 3, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
174 PLN | -0.57% | +1.87% | -11.22% |
1st Jan change | Capi. | |
---|---|---|
-11.22% | 119M | |
-41.97% | 7.92B | |
+5.99% | 3.51B | |
-4.31% | 2.18B | |
-21.69% | 1.97B | |
-24.94% | 1.58B | |
+31.45% | 1.14B | |
+26.75% | 792M | |
-9.83% | 690M | |
-26.33% | 532M |
- Stock Market
- Equities
- SCP Stock
- News Scope Fluidics S.A.
- Bio-Rad Laboratories, Inc. agreed to acquire Curiosity Diagnostics Sp. z o.o. from Scope Fluidics S.A. for $100 million.